We sold the remaining 400 shares we had of GitLab this morning. We sold the shares at $41.09 and this raised $16, 435. In the course of researching the article I am writing about Nebius, I came across a company called Cursor. While not an exact competitor, Cursor has increased its ARR by 10X to $1 billion…
The last couple of weeks have been painful for investors in high growth IT shares-brutal really. With a crescendo of bubble articles and headlines talking about stretched valuation, good news got interpreted negatively and indifferent news resulted in significant share price compression. Basically, as the year end approaches, some investors, with significant gains have moved…
I am getting this to subscribers a bit later than normal-last week’s post ran too long so this was not included. Then too, with the excitement with regards to Oracle and Nebius, my scheduling got severely impacted. Here is the list: the first 3 ideas are the companies that have just reported, i.e. Oracle, Nebius…
We added 250 shares of GitLab to our High Growth model portfolio this morning. The shares were down about 9.5% from their previous close due to headline guidance concerns. In particular, despite one of the stronger revenue beats the company has recently reported, and a bookings quarter in which cRPO balance growth remained at 31%,…
I mentioned in yesterday’s article on Tariffs and the market panic, that I was placing some limit orders. $ of them were recently filled. The high growth portfolio added 100 shares of Rubrik at $50.01 taking the position size to 1600 shares; 50 shares of Snowflake at $128.01 raising the position size to 450; 150…
The first two days of this week featured a consolidation trade after some strong or frothy trading the prior few weeks in the wake of the Trump electoral victory. Some might say a correction is overdue; in my case, particularly, I was struck by the recent nomination of new FTC Commissioners. Ticker Target is not…
This morning we made some changes in our high growth portfolio, selling the balance of the Shift 4 position and adding to positions in Datadog, SentinelOne, Unity and GitLab. The details are as follows: We sold 500 shares of Shift4 at 104.29. This eliminated the position and raised $52,140. To reiterate, our sale was related to the appointment…
a) Zscaler: The business is growing but one metric is misleading investors As I write this Tuesday evening, Zscaler shares are down 15% to around $164. That puts the year to date loss of the shares to around 13%. I point that out simply because the question to consider is whether or not the company is…
This morning Reuters published an article in which it suggests that GitLab has hired investment bankers and has seen interest from a variety of potential purchasers including Google and Amazon. Rumors about a GitLab sale have been circulating from time to time. The founder and CEO of GitLab, Sid Sijbrandij has been battling cancer and announced that his…
Sales of 1500 shares of UiPath and Sale of 150 shares of Dynatrace: Purchase of 300 shares of Nutanix, Purchase of 200 shares of GitLab As we had indicated, we have now eliminated UiPath from the portfolio. Its latest earnings report and guidance were very disappointing, and while the narrative may play out, we simply…